§ 277. Review and reports. 1. The commissioner, in consultation with
the drug utilization review board, shall undertake periodic reviews, at
least annually, of the preferred drug program which shall include
consideration of:

(a) the volume of prior authorizations being handled, including data
on the number and characteristics of prior authorization requests for
particular prescription drugs;

(b) the quality of the program's responsiveness, including the quality
of the administrator's responsiveness;

(c) complaints received from patients and providers;

(d) the savings attributable to the state, and to each county and the
city of New York, due to the provisions of this article;

(e) the aggregate amount of supplemental rebates received in the
previous fiscal year and in the current fiscal year, to date; and such
amounts are to be broken out by fiscal year and by month;

(f) the education and outreach program established by section two
hundred seventy-six of this article.

2. The commissioner and the board shall, beginning March thirty-first,
two thousand six and annually thereafter, submit a report to the
governor and the legislature concerning each of the items subject to
periodic review under subdivision one of this section.

3. The commissioner and the board shall, beginning with the
commencement of the preferred drug program and monthly thereafter,
submit a report to the governor and the legislature concerning the
amount of supplemental rebates received.